Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comprehensive Nonclinical Safety Assessment of Nirmatrelvir Supporting Timely Development of the SARS-COV-2 Antiviral Therapeutic, Paxlovid™.
Sathish JG, Bhatt S, DaSilva JK, Flynn D, Jenkinson S, Kalgutkar AS, Liu M, Manickam B, Pinkstaff J, Reagan WJ, Shirai N, Shoieb AM, Sirivelu M, Vispute S, Vitsky A, Walters K, Wisialowski TA, Updyke LW. Sathish JG, et al. Among authors: vispute s. Int J Toxicol. 2022 Aug;41(4):276-290. doi: 10.1177/10915818221095489. Epub 2022 May 21. Int J Toxicol. 2022. PMID: 35603517 Free PMC article.
Experiments in the EpiDerm 3D Skin In Vitro Model and Minipigs In Vivo Indicate Comparatively Lower In Vivo Skin Sensitivity of Topically Applied Aneugenic Compounds.
Schuler M, Tomlinson L, Homiski M, Cheung J, Zhan Y, Coffing S, Engel M, Rubitski E, Seitis G, Hales K, Robertson A, Vispute S, Cook J, Radi Z, Hollingshead B. Schuler M, et al. Among authors: vispute s. Toxicol Sci. 2021 Feb 26;180(1):103-121. doi: 10.1093/toxsci/kfaa189. Toxicol Sci. 2021. PMID: 33481035
An orthogonal methods assessment of topical drug concentrations in skin and the impact for risk assessment in the viable epidermis.
Hollingshead BD, Tomlinson L, Finley J, Doshna C, Ritenour C, Barricklow J, Oppenheimer SR, O'Neil SP, Moore JL, Patterson NH, Nicholson SP, Norris JL, Caprioli RM, Beaumont K, King-Ahmad AJ, Vispute S, Cook JC, Radi Z, Schuler M. Hollingshead BD, et al. Among authors: vispute s. Regul Toxicol Pharmacol. 2021 Jul;123:104934. doi: 10.1016/j.yrtph.2021.104934. Epub 2021 Apr 16. Regul Toxicol Pharmacol. 2021. PMID: 33872740
Cross study analyses of SEND data: toxicity profile classification.
Carfagna MA, Ahmed CS, Butler S, Fukushima T, Houser W, Jensen N, Paisley B, Leuenroth-Quinn S, Snyder K, Vispute S, Wang W, Ali MY. Carfagna MA, et al. Among authors: vispute s. Toxicol Sci. 2024 Aug 1;200(2):277-286. doi: 10.1093/toxsci/kfae072. Toxicol Sci. 2024. PMID: 38851876 Free PMC article.
Quantifying urban park use in the USA at scale: empirical estimates of realised park usage using smartphone location data.
Young MT, Vispute S, Serghiou S, Kumok A, Shah Y, Lane KJ, Black-Ingersoll F, Brochu P, Bharel M, Skenazy S, Karthikesalingam A, Bavadekar S, Kansal M, Shekel T, Gabrilovich E, Wellenius GA. Young MT, et al. Among authors: vispute s. Lancet Planet Health. 2024 Aug;8(8):e564-e573. doi: 10.1016/S2542-5196(24)00125-6. Lancet Planet Health. 2024. PMID: 39122325 Free article.
The MindMoves Trial: Cross-Sectional Analyses of Baseline Vascular Risk and Cognition in Older Women with Cardiovascular Disease.
Halloway S, Volgman AS, Barnes LL, Schoeny ME, Wilbur J, Pressler SJ, Laddu D, Phillips SA, Vispute S, Hall G, Shakya S, Goodyke M, Auger C, Cagin K, Borgia JA, Arvanitakis ZA. Halloway S, et al. Among authors: vispute s. J Alzheimers Dis. 2024;100(4):1407-1416. doi: 10.3233/JAD-240100. J Alzheimers Dis. 2024. PMID: 39031356 Clinical Trial.
36 results